Major Histocompatibility Complex Class II–Positive Cortical Epithelium Mediates the Selection of Cd4+25+ Immunoregulatory T Cells by Bensinger, Steven J. et al.
 
J. Exp. Med. 
 

 
 The Rockefeller University Press • 0022-1007/2001/08/427/12 $5.00
Volume 194, Number 4, August 20, 2001 427–438
http://www.jem.org/cgi/content/full/194/4/427
 
427
 
Major Histocompatibility Complex Class II–positive
Cortical Epithelium Mediates the Selection of
 
CD4
 
 
 
25
 
 
 
 Immunoregulatory T Cells
 
Steven J. Bensinger,
 
1
 
 Antonio Bandeira,
 
3
 
 Martha S. Jordan,
 
2
 
Andrew J. Caton,
 
2
 
 and Terri M. Laufer
 
1
 
1
 
Department of Medicine, University of Pennsylvania, and the 
 
2
 
Wistar Institute, 
Philadelphia, PA 19104
 
3
 
Institut Pasteur, Paris 75015, France
 
Abstract
 
CD4
 
 
 
25
 
 
 
 T cells are a unique population of immunoregulatory T cells which are critical for
the prevention of autoimmunity. To address the thymic selection of these cells we have used
 
two models of attenuated thymic deletion. In K14-A
 
 
 
b
 
 mice, major histocompatibility complex
(MHC) class II I-A
 
b
 
 expression is limited to thymic cortical epithelium and deletion by he-
 
matopoietic antigen-presenting cells does not occur. In H2-DM
 
 
 
–deficient mice, MHC class
II molecules contain a limited array of self-peptides resulting in inefficient clonal deletion. We
find that CD4
 
 
 
25
 
 
 
 T cells are present in the thymus and periphery of K14-A
 
 
 
b
 
 and H2-DM
 
 
 
–
deficient mice and, like their wild-type counterparts, suppress the proliferation of cocultured
CD4
 
 
 
25
 
 
 
 effector T cells. In contrast, CD4
 
 
 
25
 
 
 
 T cells from MHC class II–deficient mice do
not suppress responder CD4
 
 
 
 T cells in vitro or in vivo. Thus, development of regulatory
CD4
 
 
 
25
 
 
 
 T cells is dependent on MHC class II-positive thymic cortical epithelium. Further-
more, analysis of the specificities of CD4
 
 
 
25
 
 
 
 T cells in K14-A
 
 
 
b
 
 and H2-DM
 
 
 
–deficient
mice suggests that a subset of CD4
 
 
 
25
 
 
 
 T cells is subject to negative selection on hematopoi-
etic antigen-presenting cells.
Key words: autoimmune disease • self-tolerance • thymic development • IL-2 receptor 
 
 
 
 
chain (CD25) • suppressor T cells
 
Introduction
 
The thymic development of T cells results in the acquisi-
tion of both immunologic tolerance to self and reactivity to
foreign antigenic stimuli. The developmental processes of
positive selection or self-restriction and negative selection
or self-tolerance are compartmentalized within the thymus.
The critical and unique function of thymic cortical epithe-
lium in supporting positive selection of CD4
 
 
 
 T cells is
well accepted (1, 2). Conversely, multiple tissue types can
mediate the opposing process of negative selection. Interac-
tions between immature T cells and bone marrow–derived
APCs, particularly dendritic cells, lead to tolerance via
clonal deletion (3–5). In addition to APCs, thymic medul-
lary epithelium can mediate incomplete deletion of high af-
finity thymocytes reactive to both endogenous mouse
mammary tumor virus superantigens and MHC–peptide
ligands (6, 7). The question of whether clonal deletion or
tolerance induction can occur in the cortex remains con-
troversial and the accepted view is that the thymic medulla
is the primary site of negative selection.
Interactions between immature T cells and thymic epi-
thelium can also result in tolerance via nondeletional
mechanisms. Early studies of murine radiation chimeras
showed that functional unresponsiveness, rather than clonal
deletion, was induced to self-antigens expressed by radiore-
sistant thymic epithelium (8). Similarly, nude mice grafted
with allogeneic fetal thymic epithelium devoid of hemato-
poietic precursors acquired donor-specific tolerance to
heart and skin transplants but rejected both third party
grafts and donor-specific hematopoietic cells (9–11). In this
system, transplant tolerance could be transferred by CD4
 
 
 
cells to naive nude mice and was “dominant” over the al-
loreactive effector cells. These experiments suggested that
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Selection of CD4
 
 
 
25
 
 
 
 T Cells
 
donor-specific tolerance to allografts generated by thymic
epithelium was mediated by “regulatory” CD4
 
 
 
 T cells.
Separate experiments have implicated CD4
 
 
 
 regulatory
cells generated in the thymus in the prevention of autoim-
munity. Studies in two different systems have identified a
population of CD4
 
 
 
 T cells constitutively expressing the IL-2
receptor 
 
 
 
 chain, CD25, which function as immunoregula-
tory cells. In the first model, peripheral mature CD4
 
 
 
 T
cells depleted of the CD4
 
 
 
CD25
 
 
 
 population induced or-
gan-specific autoimmunity when inoculated into histocom-
patible T cell–deficient 
 
nu/nu
 
 mice (12, 13). In the second
model, genetically susceptible mice thymectomized on day 3
of life (3dTx)
 
*
 
 developed similar organ-specific autoimmune
disease (14, 15). The disease process in 3dTx mice was in-
duced by CD4
 
 
 
 cells but could be inhibited by normal adult
CD4
 
 
 
 cells; the inhibitory activity was again contained in
the subset of CD4
 
 
 
 cells coexpressing CD25 (16).
There is strong evidence that regulatory CD4
 
 
 
CD25
 
 
 
T cells develop and acquire their suppressive phenotype in
the thymus (17–19). Clearly, the development of autoim-
munity in 3dTx mice suggests a requirement for an intact
thymus in the preservation of peripheral tolerance. Closer
examination of CD4
 
 
 
CD25
 
 
 
 thymocytes demonstrate that
they comprise 
 
 
 
5% of the CD4 single positive (SP) pool
and have a regulatory phenotype similar to their peripheral
counterparts (18, 19). They can prevent autoimmunity
when adoptively transferred into 3dTx mice or, with
CD4
 
 
 
CD25
 
 
 
 effector cells, into 
 
nu/nu
 
 hosts (18). Intrathy-
mic transfer experiments suggest that CD4
 
 
 
25
 
 
 
8
 
 
 
 thy-
mocytes arise from double negative thymocyte precur-
sors, and fluorochrome labeling has demonstrated that
CD4
 
 
 
CD25
 
 
 
 cells emigrate from the thymus to populate
the periphery (17, 18).
In several experimental systems, the expression of a regu-
latory cell phenotype does not occur until cells have en-
tered the CD4 SP thymocyte pool (17–19). Recently, two
of us (M.S. Jordan and A.J. Caton, Wistar Institute) have
shown that an agonist peptide reexpressed as self on thymic
epithelium is sufficient for the generation of functionally
suppressive CD4
 
 
 
CD25
 
 
 
 T cells (19). Given that acquisi-
tion of a cell surface phenotype characteristic of regulatory
CD4
 
 
 
 T cells (such as CD25) occurs “relatively late” dur-
ing CD4-SP development, it has been suggested that the
generation of regulatory CD4
 
 
 
CD25
 
 
 
 T cells is the result
of high affinity interactions with medullary epithelium (19,
20). While this model system demonstrated that thymic ep-
ithelium is sufficient for the development of these cells, it
was unable to place the generation of CD4
 
 
 
CD25
 
 
 
 T cells
in the context of positive and negative selection.
We have delineated the thymic development of CD4
 
 
 
CD25
 
 
 
 cells in two different models of attenuated nega-
tive selection. In K14-A
 
 
 
b
 
 mice, an MHC class II I-A
 
b
 
transgene is expressed only on thymic cortical epithelium;
both medullary epithelium and bone marrow–derived
 
APCs are class II-negative (21). Clonal deletion of CD4
 
 
 
 T
cells cannot be documented, and CD4
 
 
 
 T cells react in
MLRs to I-A
 
b
 
–positive hematopoietic APCs. H2-DM
 
 
 
–
deficient mice have H-2A
 
b
 
 molecules loaded almost exclu-
sively with the class II–associated invariant chain peptide
(22–24). The CD4
 
 
 
 T cells selected in H2-DM
 
 
 
–deficient
mice are not tolerant to the broad array of peptides ex-
pressed by wild-type APCs and these cells also react vigor-
ously in MLRs against B6 hematopoietic APCs (22, 23). In
both K14-A
 
 
 
b
 
 and H2-DM
 
 
 
–deficient mice, the introduc-
tion of I-A
 
b
 
-positive hematopoietic APCs eliminates these
autoreactive cells (25, 26). Thus, clonal deletion is deficient
in both K14-A
 
 
 
b
 
 and H2-DM
 
 
 
–deficient mice. The non-
deletional mechanisms of T cell tolerance have not been
examined in these models.
The data presented herein demonstrate that CD4
 
 
 
25
 
 
 
 T
cells are selected on cortical epithelium and that these cog-
nate interactions are sufficient for the phenotypic and func-
tional development of CD4
 
 
 
CD25
 
 
 
 immunoregulatory T
cells. Furthermore, analysis of the specificities of CD4
 
 
 
25
 
 
 
T cells in K14-A
 
 
 
b
 
 and H2-DM
 
 
 
–deficient mice suggests
that a subset of CD4
 
 
 
25
 
 
 
 T cells is subject to negative se-
lection on hematopoietic APCs.
 
Materials and Methods
 
Mice.
 
C57BL/6 (designated WT or B6 in text) and C57Bl/6
recombination activating gene 2-deficient (Rag-2
 
 
 
) were pur-
chased from The Jackson Laboratory or Centre de Dévelopment
des Techniques Avancées pour l’experimentation animale (Or-
leans, France). The MHC class II–deficient mice (27), K14-A
 
 
 
b
 
mice (21), and H2-DM
 
 
 
–deficient mice (24) have been described
previously. H2-DM
 
 
 
–deficient mice were a gift from Luc van
Kaer (Vanderbilt University, Nashville, TN) and are seven gener-
ations backcrossed onto a C57BL/6 background. Both K14-A
 
 
 
b
 
and MHC class II–deficient mice are
 
  
 
20 generations. All mice
were maintained under SPF conditions in the animal facilities of
the University of Pennsylvania or the Institut Pasteur.
 
Media, Reagents, Antibodies, and Flow Cytometry.
 
All cells were
grown in RPMI 1640 (Mediatech) supplemented with 10% heat-
inactivated FCS, 100 U/mL penicillin, 100 
 
 
 
g/ml streptomycin, 2
mm 
 
L
 
-glutamine, 10 mm Hepes (all from GIBCO BRL), and 50
 
 
 
m 2-ME (Sigma-Aldrich). FITC and biotin–anti-CD25 (7D4),
PE, and APC–anti-CD4 (RM4-5), and streptavidin–PE were pur-
chased from BD PharMingen. Purified anti-CD3
 
 
 
 (2C11) was pur-
chased from Accurate. Murine rIL-2 was purchased from Pepro-
tech. Cells were analyzed on a Becton Dickinson FACSCalibur™
using CELLQuest™ software (Becton Dickinson).
 
Cell Purification.
 
Thymocytes, LN, and spleen cells were ini-
tially prepared by lysing erythrocytes with ACK lysis buffer. Cell
preps were then enriched for CD4
 
 
 
 T cells by negative selection.
Single cell suspensions were incubated with anti-CD8 (2.43),
anti-B220 (RA3), anti-MAC-1(M1/70.15), F4/80, and anti-
MHC class II (M/5114) culture supernatants for 30 min at 4
 
 
 
C
followed by incubation with microbead-conjugated goat anti–rat
IgG (PolySciences, Inc.) for 30 min at 4
 
 
 
C. Cell preps were
placed on a Bio-Mag magnetic stand (PolySciences, Inc.) and the
negative fraction was harvested. CD4
 
 
 
25
 
 
 
 T cells were subse-
quently labeled with biotin–anti-CD25 (7D4), APC-anti-CD4
(RM4-5), and streptavidin–PE and purified by flow cytometry
 
*
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on a FACSVantage™ Cell Sorter (Becton Dickinson). The pu-
rity of CD4 25  T cells was  95%.
Proliferation Assays. In anti-CD3  stimulated proliferation as-
says, CD4 25  cells (5   104) were cultured in 96-well plates
with MHC class II–deficient APCs (105) or B6 APCs as in-
dicated, 1  g/ml anti-CD3 , and the indicated numbers of
CD4 25  cells for 72 h at 37 C/5% CO2. In the K14-A 
b anti-
B6 MLR or H2-DM –deficient anti-B6 MLR, either K14-A 
b
or H2-DM –deficient CD4 25  cells (5   104) were cultured
in 96-well plates with 1–2   105 irradiated, T cell–depleted B6
or H2-DM –deficient spleen cells as indicated. B6, MHC class
II–deficient, or H2-DM –deficient stimulators (APCs) were
initially prepared by erythrocyte lysis with ACK buffer. APCs
were incubated with anti-Thy 1.2 (MMT1), anti-CD4 (172.4),
and anti-CD8 (TIB-211) for 45 min on ice. APCs were subse-
quently incubated with rabbit complement (Accurate Antibod-
ies) for 45 min at 37 C. APCs were then irradiated at 2,500 rad
of   -irradiation. MLRs were cultured for 96 h at 37 C/5%
CO2, pulsed with 3[H]thymidine for the final 16 h, and har-
vested on an automatic harvester (Wallac). All proliferation ex-
periments were set up in triplicate and results are expressed as a
mean of triplicates.
CFSE Labeling and Adoptive Transfers. Donor CD4  T cells were
purified and enriched from spleen and LNs by negative selection
Figure 1. K14-A 
b mice have CD4 25  T cells. (A) Total LN cells
from K14-A 
b or B6 (WT) were stained with APC-conjugated anti-CD4,
Percp-conjugated anti-CD8, and FITC-conjugated anti-CD25 as in Ma-
terials and Methods. Percentages indicated in histograms are of live CD4 
lymphocytes. (B) Total thymocytes from K14-A 
b or B6 (WT) mice were
stained with APC-conjugated anti-CD4, Percp-conjugated anti-CD8,
and biotin-conjugated anti-CD25 followed by PE-conjugated streptavi-
din. Histograms are gated through live CD4-single positive thymocytes.
Percentages indicated are of live CD4-single positive thymocytes.430 Selection of CD4 25  T Cells
as indicated above. Single cell suspensions were labeled with
CFSE (Molecular Probes) as described previously (28). A total of
1–3   107 CFSE-labeled C57BL/6 CD4  T cells were injected
intravenously into indicated mice in a total volume of 0.2 mL
sterile PBS. Recipients were killed at 72 h and spleen and LNs
were harvested. Total spleen and LN cells were purified, labeled
with APC–anti-CD4 (RM4-5) and analyzed by flow cytometry
as above.
Induction of Inflammatory Bowel Disease. For the preparation of
CD45RBhigh CD4 T cells, C57Bl/6-Thy1.1 splenic single cell
suspensions were first enriched for CD4  by positive selection on
midiMacs™ columns (Miltenyi Biotec) according to the manu-
facturer’s instructions. In brief, cells were first incubated with
anti-CD4–FITC antibodies for 20 min on ice in PBS supple-
mented with 0.5% FCS, then incubated in the same buffer with
anti-FITC microbeads for 15 min. The magnetically labeled pos-
itive fraction was retained on a midiMacs column. After enrich-
ment, the cells were then labeled with anti-CD45RB-PE anti-
bodies for 20 min on ice and then sorted on a FACStarPlus™
(Becton Dickinson). For CD45RB, the brightest 40–50% of
CD4  cells were sorted as “high.” The purity of the population
was  96%. For the preparation of CD25  CD4 T cells, splenic
single cell suspensions were enriched by positive selection on mi-
diMacs columns with anti-CD25–FITC or biotin-labeled anti-
bodies followed by anti-FITC or streptavidin–PE magnetic mi-
crobeads. Given that class II  mice contain very low numbers of
CD25  CD4 T cells, instead of sorting, one or two additional
rounds of magnetic sorting was performed. For all populations,
 95% of the CD4 T cells were CD25 .
6–8-wk-old C57Bl/6 RAG-2  mice were injected intrave-
nously with 3   105 CD4 CD45RBhigh T cells either alone or
with 3   105 purified CD4 25  T cells. Mice were monitored
and weighed every other day and killed if they lost 20% of their
initial body weight, had extensive diarrhea, or appeared morbidly
ill. Whole intestines were first flushed extensively to eliminate
the lumen content, then longitudinally opened and cut into 0.5
cm pieces for fixation in PBS-buffered formalin before section-
ing. Paraffin sections were stained with H&E.
Results
CD4 CD25  Regulatory T Cells Are Present in K14-A 
b
Mice. To understand the thymic requirements for the de-
velopment of CD4 25  T cells, we compared the pheno-
type and function of these cells in K14-A 
b and wild-type
C57BL/6 (B6) mice. Flow cytometric analysis of LNs and
spleen revealed that peripheral K14-A 
b CD4  T cells
expressed CD25 (Fig. 1 A). Like B6 mice, K14-A 
b
CD4 CD25  cells are also found in the mature CD4 SP
thymocyte pool (Fig. 1 B).
To determine if these cells have immunoregulatory char-
acteristic similar to their wild-type counterparts, purified
CD4 CD25  T cells from K14-A 
b or B6 animals were cul-
tured for 3 d with T cell–depleted, MHC class II–deficient
APCs and soluble anti-CD3  antibody, with or without ex-
ogenous rIL-2. In this and the following assay, MHC class
II–deficient APCs were used as K14-A 
b CD4  cells re-
spond to I-Ab-positive (B6) APCs (21). CD4 CD25  T
cells from both B6 mice and K14-A 
b mice did not prolifer-
ate to anti-CD3  stimulation unless provided with exoge-
nous rIL-2 (Fig. 2 A). Thus, these data demonstrate that both
K14-A 
b and B6 CD4 CD25  T cells are anergic in vitro.
To examine suppressor function (29, 30), a fixed number
(5   104 cells) of K14-A 
b or wild- type B6 CD4 CD25 
effector T cells were cultured with T cell–depleted, MHC
class II–deficient APCs, and soluble anti-CD3  in the pres-
ence of increasing numbers of CD4 CD25  lymphocytes
from the same strain. Proliferation of responder K14-A 
b
and B6 CD4 25  T cells was inhibited by the addition of
CD4 25  T cells to cultures in a dose-dependent fashion
(Fig. 2 B). The ratios of K14-A 
b CD4 25  cells required
to suppress the proliferation of a fixed number of effector
cells were equivalent to wild-type regulatory cells. For ex-
ample, a final effector to responder ratio of 1:1 resulted in
Figure 2. K14-A 
b CD4 25  cells are anergic and suppressive. (A) CD4 25  cells (5   104) from K14-A 
b or B6 (WT) were cultured with MHC
class II-negative APCs (105), soluble anti-CD3  (1  g/ml), and rIL-2 (10 U/ml) for 72 h, pulsed with [3H]thymidine for 16 h and harvested. (B)
CD4 25  cells (5   104) from K14-A 
b or B6 mice were incubated with MHC class II-negative APCs (105), soluble anti-CD3  (1  g/ml), and the in-
dicated number of CD4 25  cells from K14-A 
b or B6 mice for 72 h, pulsed with [3H]thymidine for the final 16 h and harvested. Results are represen-
tative of three experiments.431 Bensinger et al.
an 80% inhibition of CD4 25  proliferation in both K14-
A 
b and B6 cultures. Thus, K14-A 
b CD4 25  T cells ap-
pear functionally indistinguishable from wild-type regula-
tory CD4 25  T cells.
Development of CD4 25  Regulatory T Cells Requires
MHC Class II Expression. K14-A 
b mice were generated
on a MHC class II–deficient background and MHC class
II–deficient mice contain CD4  T cells which are re-
stricted to classical and nonclassical MHC class I antigens
(31). Thus, it was possible that the CD4 25  T cells
present in K14-A 
b mice were selected on MHC class I an-
tigens. We addressed this possibility by (i) examining the
phenotype and function of CD4 25  T cells in MHC class
II–deficient mice and (ii) generating K14-A 
b mice lacking
 2-microglobulin ( 2m) and MHC class I antigens (desig-
nated K14-A 
b/ 2m /  in this text).
A significant fraction of the residual CD4  T cells
present in LNs and the spleen of MHC class II–deficient
Figure 3. MHC class II–deficient CD4 25  T cells
are not functional suppressors. (A) Total LN cells from
MHC class II–deficient mice were stained with APC-
conjugated anti-CD4, Percp-conjugated anti-CD8,
and FITC-conjugated anti-CD25 as in Materials and
Methods. Percentages indicated in histograms are of
live CD4  lymphocytes. (B) CD4 25  cells (5   104)
from B6 mice were incubated with B6 APCs (105),
soluble anti-CD3  (1  g/ml), and the indicated num-
ber of CD4 25  cells from MHC class II–deficient or
B6 mice for 72 h, pulsed with [3H]thymidine for the
final 16 h and harvested. Results are representative of
two experiments. (C and D) Class II–deficient
CD4 25  cells can not prevent wasting and inflam-
matory bowel disease. B6-Rag-2  recipients received
3   105 B6 CD4 45RBhigh cells either alone or with
3   105 CD4 25  cells from K14-A 
b, MHC class II–
deficient, or B6 CD4 25  cells. Results are represen-
tative of two experiments. (C) Shown are the percentages of initial body weight for individual mice on the day of killing. (D) H&E histology of colonic
sections from individual animals which received effector cells and either MHC class II–deficient, K14-A 
b, or B6 CD4 25  cells. Note the extensive
mononuclear cell infiltrates, mucosal hyperplasia, and crypt abscesses in the recipients of MHC class II–deficient CD4 25  cells.432 Selection of CD4 25  T Cells
mice express CD25 (Fig. 3 A, and data not shown). To ex-
amine the suppressor function of these cells, a fixed number
of B6 CD4 CD25  effector T cells were cultured with T
cell–depleted, B6 APCs, and soluble anti-CD3 . In addi-
tion, indicated cultures (Fig. 3 B) received an equal num-
ber of FACS®-sorted B6 or MHC class II–deficient
CD4 CD25  T cells. CD4 CD25  T cells from MHC
class II–deficient mice did not suppress the proliferation of
wild-type effector T cells. Rather, the addition of these
cells to B6 CD4 CD25  effector T cells resulted in a two
to threefold increase in the proliferation of cultured cells
(Fig. 3 B). Thus, MHC class II–deficient CD4 CD25  T
cells are functionally distinct from B6 CD4 CD25  T cells
as they do not have regulatory activity.
FACS®-sorted CD4 25  lymphocytes from K14-A 
b/
 2m /  (MHC class I–deficient) mice cultured with re-
sponders at a final effector to responder ratio of 1:1 resulted
in an 85% inhibition of proliferation (data not shown).
Thus, these cells have the same suppressive capabilities as
those from MHC class I–sufficient K14-A 
b mice, suggest-
ing again that selection of these cells is MHC class II
dependent. Taken together, these data suggest that the im-
munoregulatory CD4 25  T cells which are present in
K14-A 
b mice require MHC class II expression on cortical
epithelium for their selection.
Thymic Expression of MHC Class II Is Sufficient for the
Generation of Regulatory CD4 25  Cells. The suppressive
function of immunoregulatory CD4 25  T cells is ac-
quired in the thymus (18, 19) and purified K14-A 
b
CD4 25  SP thymocytes did not proliferate to TCR sig-
nals unless exogenous rIL-2 was added to cultures (Fig. 4
A). Furthermore, K14-A 
b CD4 25  SP thymocytes
suppressed proliferation of anti–CD3 -treated K14-A 
b
CD4 25  effector cells similarly to peripheral K14-A 
b
CD4 25  T cells examined in parallel (Fig. 4 A). Thus,
K14-A 
b CD4 25  thymocytes are anergic and sup-
pressive. These data confirm that selection on MHC
class II-positive cortical epithelium is sufficient for the
Figure 4. K14-A 
b CD4 25  T cells are generated in
the thymus. (A) CD4 25  cells (5   104) from K14-A 
b
mice were incubated with MHC class II-negative APCs
(105), soluble anti-CD3  (1  g/ml), and the indicated
number of K14-A 
b CD4 25  thymocytes or peripheral
K14-A 
b CD4 25  cells for 72 h, pulsed with [3H]thy-
midine for 16 h, and harvested. Results are representa-
tive of three experiments. (B) CFSE-labeled, alloreactive
H-2bm12CD4  cells (107) were intravenously injected into
indicated hosts. After 72 h animals were killed. LN and
spleen cells were stained with APC-conjugated anti-
CD4, and analyzed by FACS®. Histograms are gated on
live CD4  splenocytes. This figure is representative of
four independent experiments.433 Bensinger et al.
complete development of CD4 25  immunoregulatory
T cells.
The suppressive ability of K14-A 
b CD4 25  cells sug-
gests that peripheral expression of MHC class II molecules
is not required for the functional and phenotypic develop-
ment of these cells. However, it remained possible that
these immunoregulatory thymocytes could derive from ac-
tivated recirculating cells (32). Therefore, it was important
to establish that K14-A 
b mice do not express functional
MHC class II antigens in the periphery.
The division of transferred CFSE-labeled alloreactive
CD4  T cells is a very sensitive measure of functional
MHC class II expression in host mice (33, 34). We trans-
ferred alloreactive CFSE-labeled H-2bm12 CD4  T cells
into K14-A 
b, MHC class II–deficient, or B6 mice and ex-
amined their proliferation after 72 h. Alloreactive H-2bm12
CD4  T cells extensively divide 72 h after transfer into B6
hosts and localize in the spleen (Fig. 4 B) and LNs (data
not shown). In contrast, no cells undergoing division were
identified 72 h after H-2bm12 CD4  T cells were trans-
ferred into either K14-A 
b or class II–deficient mice. Sim-
ilar results were obtained when host mice were sublethally
irradiated with 450 rads of whole body  -irradiation 48 h
before adoptive transfer (data not shown). These results do
not directly address the requirement for peripheral anti-
gens in the development of regulatory T cells which can
suppress organ-specific autoimmune disease. However,
they do supply functional corollaries to our earlier immu-
nohistochemical and FACS® data that MHC class II anti-
gens are not available in the periphery of K14-A 
b mice
(21), and suggest that peripheral cognate T cell–MHC
interactions are not required for the development of
CD4 25  regulatory cells.
K14-A 
b CD4 25  T Cells Prevent Inflammatory Colitis.
To examine their in vivo  function, CD4 25  fractions
were sorted from B6, K14-A 
b, or MHC class II–deficient
mice and tested for their ability to inhibit the colitis in-
duced by transfer of CD4 45RBhigh cells into Rag-2  re-
cipients. It has been reported that severe combined immu-
nodeficient mice reconstituted with 3   105 CD4 45RBhi
B6 effector T cells develop an inflammatory bowel syn-
drome (IBD) which results in severe wasting and histologi-
cally resembles Crohn’s disease (35, 36). In this model, the
wasting and IBD can be controlled by the cotransfer of
CD4 25  T cells (37, 38).
B6 CD4 45RBhigh effector CD4 cells were transferred
into B6 Rag-2  mice either alone or with CD4 CD25 
cells purified from K14-A 
b, class II , or B6 mice. Animal
weight was monitored every other day and animals were
killed either when they had lost 20% of their body weight,
had significant diarrhea, or between days 40 and 44.
Effector CD4 45RBhigh cells alone induced an overt
wasting disease with diarrhea and weight loss (Fig. 3 C) as-
sociated with colonic thickening and inflammatory infil-
tration of the colon (data not shown). Cotransfer of either
B6 or K14-A 
b CD4 CD25  cells prevented intestinal in-
flammation; recipient mice gained weight over the course
of the experiment and had normal colonic histology (Fig.
3, C and D).  In contrast, recipients of cotransfered
CD4 45RBhigh effector T cells and MHC class II–defi-
cient CD4 CD25  T cells developed severe wasting diar-
rhea and weight loss. These symptoms were associated
with chronic colitis with hyperplasia of the glandular mu-
cosae, increased numbers of crypts, and diffuse mononu-
clear cell infiltration. These results support the in vitro ob-
servations that K14-A 
b CD4 25  regulatory T cells are
functionally similar to the regulatory T cells present in
wild-type mice. Secondly, the population of CD4  cells
present in MHC class II–deficient mice which expresses
CD25 (presumably as an activation marker) do not have
this regulatory function.
The K14-A 
b CD4 25   Repertoire Contains Autoreactive
Cells. The experiments presented above show that regu-
latory cells which developed in either B6 or K14-A 
b mice
could inhibit an inflammatory process mediated by B6 ef-
fector cells. However, the effector T cell responses in this
model of IBD are promoted by bacterial antigens, rather
than self-antigens (37). Therefore, we asked if CD4 25  T
cells could control the activation of a polyclonal self-reac-
tive repertoire. K14-A 
b CD4  T cells proliferate vigor-
ously in vitro to B6 APCs (21). These in vitro MLRs were
performed using unfractionated K14-A 
b CD4  T cells in
which the ratio of CD25  to CD25  cells is  10–15:1.
Ratios of K14-A 
b CD25  regulatory to CD25  effector
cells of 1:1 are required to inhibit 80% of anti-CD3 -
induced proliferation (Fig. 2 B). Therefore, we examined
the regulatory function of CD4 25  cells in an MLR at a re-
sponder to suppressor ratio of 1:1. Purified K14-A 
b
CD4 25  effector proliferated significantly to  -irradiated,
T cell–depleted B6 hematopoietic APCs in an MLR. The
addition of an equal number of K14-A 
b CD4 25  T cells
to this MLR suppressed the proliferation of B6-reactive
K14-A 
b responder cells in this MLR to 10% of the unsup-
pressed level (Fig. 5 A). Strikingly, CD4 25  cells purified
from B6 mice were unable to significantly suppress the
anti-B6 proliferation of K14-A 
b CD4 25  responders at
similar ratios (Fig. 5 A).
It was possible that B6 CD4 25  T cells failed to inhibit
the K14-A 
b anti-B6 MLR because regulatory T cells only
suppressed the activity of syngeneic cells. However, after
stimulation via anti-CD3  added to the culture, B6
CD4 25  T cells could suppress the K14-A 
b CD4 25 
anti-B6 MLR (Fig. 5 A). CD4 25  T cells require TCR
signals to become active suppressors (29, 30) and these re-
sults suggest that B6 CD4 25  T cells were not activated
by B6 APCs, and therefore could not suppress a K14-A 
b
anti-B6 MLR. In contrast, K14-A 
b CD4 25  cells re-
ceived activation signals from B6 hematopoietic APCs to
block an I-Ab reactive MLR.
This pattern of restriction of the CD25  fraction of
CD4  cells mirrors total CD4  T cells from these respec-
tive mice: K14-A 
b CD4  T cells proliferate in MLR to
syngeneic B6 APCs; B6 CD4  T cells do not (21). To di-
rectly test if K14-A 
b CD4 25  T cells were reactive to
I-Ab-positive APCs, we cultured FACS®-purified K14-A 
b
or B6 CD4 25  lymphocytes (from LNs and spleen) with434 Selection of CD4 25  T Cells
 -irradiated, T cell–depleted B6 splenocytes and measured
the proliferative response. We previously observed that
CD4 25  T cells were unresponsive to stimulation with
anti-CD3  Ab. Consistent with these results, neither B6
nor K14-A 
b CD4 25  cells proliferated in the presence of
B6 APCs. However, when exogenous rIL-2 was added to
cultures, K14-A 
b CD4 25  T cells proliferated to the
same extent as K14-A 
b CD4 25  when stimulated by B6
APCs. In contrast, B6 CD4 25  T cells proliferated only
minimally (Fig. 5 B). Furthermore, the addition of Y-3P
(39), an anti-I-Ab–blocking antibody, to cultures signifi-
cantly inhibited the proliferation of K14-A 
b CD4 25  T
cells (data not shown) confirming that the reactivity of
these cells is I-Ab dependent. Thus, the specificity of K14-
A 
b CD4 25  cells is significantly different from B6 mice
but similar to the CD4 25  effector cells from K14 mice.
The H-2DM –deficient CD4 25   Repertoire also Contains
I-Ab Reactive Suppressor Cells. Both CD4 25  effector cells
and CD4 25  regulatory T cells in K14-A 
b mice have
significant reactivity to syngeneic I-Ab-positive B6 APCs.
Based on our observation that K14-A 
b CD4 25  T cells
contain an autoreactive repertoire we hypothesized that,
similarly to CD4  effector cells, CD4 25  T cells which
react to MHC class II-positive hematopoietic thymic APCs
undergo clonal deletion. To extend this hypothesis, we ex-
amined the function of CD4 25  T cells in another model
of attenuated negative selection, the H2-DM –deficient
mouse (22–24).
Flow cytometric analysis demonstrated that CD4 25 
cells were present in the thymus and periphery of H-2DM -
deficient mice (Fig. 6 A, and data not shown). H2-DM –
deficient CD4  cells react in MLRs against wild-type
(B6) APCs loaded with a broad array of I-Ab–associated
peptides (22–24). Therefore, we asked if, similar to K14-
A 
b regulatory cells, H-2DM –deficient CD4 25  T cells
could be activated by B6 hematopoietic APCs to sup-
press this proliferation, confirming a role for negative selec-
tion in shaping the CD4 25  repertoire. The addition of
purified H-2DM –deficient CD4 25  suppressor cells to
H-2DM –deficient CD4 25  T cells culture at a ratio of
1:1 inhibited this proliferation to  1% of effector T cell
proliferation. Again, FACS®-sorted CD4 25  cells from
B6 mice had no significant effect on this anti–I-Ab prolifer-
ation, unless TCR signals were provided by the addition of
antibodies to CD3  (Fig. 6 B).
To determine if, similar to K14-A 
b regulatory cells, H2-
DM –deficient CD4 25  T cells were activated by B6
I-Ab molecules expressing a broad array of peptides,
CD4 25  cells were cocultured with either self H2-DM –
deficient APCs or B6 APCs with or without exogenous
rIL-2. As shown in Fig. 6 C, H2-DM –deficient regula-
tory cells did not proliferate significantly to self H2-DM –
deficient APCs in the presence of rIL-2. In contrast, H2-
DM –deficient CD4 25  T cells proliferated vigorously
when stimulated with B6 APCs in the presence of exoge-
nous rIL-2. Thus, CD4 25  T cells are tolerant to the rep-
ertoire of self-peptides on hematopoietic APCs and reac-
tive to foreign antigen suggesting that the repertoire of
these cells grossly mirrors that of the effector CD4  T cell
populations which develop in the same thymus.
Discussion
It is generally accepted that CD4 25  T cells are gener-
ated in the thymus, however, the selection events involved
in the development of these cells remain poorly defined. In
this report, we have taken a reductionist approach to deter-
mine the cognate interactions which are sufficient for the
complete development of CD4 25  immunoregulatory T
cells. We find that CD4 25  T cells are present in the thy-
mus and periphery of K14-A 
b and DM -deficient mice.
Like their wild-type counterparts, these cells do not prolif-
erate to TCR-mediated stimulation unless exogenous IL-2
is provided, and their activation dominantly suppresses the
proliferation of cocultured responder CD4  T cells. We
Figure 5. K14-A 
b CD4 25 
cells are activated by I-Ab-posi-
tive APCs. (A) CD4 25  T cells
(5    104) from K14-A 
b mice
were incubated with T cell–
depleted B6 splenocytes. The in-
dicated wells also received either
K14-A 
b CD4 25  cells (5   104),
B6 CD4 25  cells (5   104), or
WT CD4 25  cells (5    104),
and anti-CD3  (1  g/ml). Wells
were cultured for 96 h and pulsed
with [3H]thymidine for 16 h and
harvested. (B) CD4 25  cells (5  
104) from K14-A 
b or B6 mice
were cultured with B6 spleno-
cytes (105) and rIL-2 (10 U/ml)
in the indicated wells for 96 h,
pulsed with [3H]thymidine for
the final 16 h, and harvested.
Results are representative of
three experiments.435 Bensinger et al.
also demonstrate that the repertoire of CD4 25  T cells
from two distinct models of attenuated negative selection,
K14-A 
b and DM -deficient mice, contain I-Ab reactive
specificities, whereas B6 mice do not. Taken together, these
data indicate that CD4 25  T cells are selected on thymic
cortical epithelium and that cognate interactions with MHC
class II on cortical epithelium are sufficient for the develop-
ment of CD4 25  regulatory T cells. Our data also suggest
that a subset of developing CD4 25  T cell population are
subject to negative selection on hematopoietic APCs.
Thymic Generation of CD4 25  Cells. To prove that
the regulatory population of CD4 25  cells was class II de-
pendent, we examined the phenotype and function of
CD4 25  T cells in MHC class II-negative mice. As we
noted above, a significant percentage of the CD4  T cells
remaining in MHC class II–deficient mice are CD25-posi-
tive (Fig. 3 A). However, we found that CD4 25  T cells
purified from MHC class II-negative mice do not suppress
the proliferation of cocultured effector CD4  T cells in
vitro (Fig. 3 B). Hence, CD4 25  T cells in MHC class II-
negative mice are functionally distinct from CD4 25  im-
munoregulatory T cells. Therefore, the development of
regulatory CD4 25  T cells requires the thymic expression
of MHC class II molecules.
Previous examination of CD4 25  T cell development
suggested that thymic differentiation of these immunoregu-
latory T cells occurred at a late stage of CD4  T cell devel-
opment. These conclusions were based on BrdU labeling
studies which demonstrated that these cells were not de-
rived from CD25  CD4 8  double positive (DP) thy-
mocytes and, separately, that expression of the CD25 anti-
gen was not apparent until the CD4  SP stage (17, 19).
Early models proposed that the differentiation of immuno-
regulatory CD4  T cells resulted from cognate interactions
with self-antigens on hematopoietic APCs of sufficient af-
finity for the induction of anergy and the acquisition of
suppressive characteristics but of insufficient affinity to in-
duce clonal deletion (18, 40). In contrast, a recent report
has used transgenic/bone marrow chimeras to show that
immunoregulatory CD4 25  T cells are generated by high
affinity interactions with self-peptide on thymic epithelium
rather than hematopoietic APCs (19). This developmental
pathway is reminiscent of the tissue requirements for the
induction of nondeletional transplant tolerance to epithelial
Figure 6. DM -deficient CD4 25  T cells also contain
I-Ab reactive specificities. (A) Total LN cells from DM -defi-
cient or B6 mice were stained with APC-conjugated anti-
CD4, Percp-conjugated anti-CD8, and FITC-conjugated anti-
CD25. Percentages in histogram are live CD4  lymphocytes.
(B) CD4 25  cells (5   104) from DM -deficient or B6 mice were incubated with T cell–depleted B6 splenocytes (2   105). Additionally, indicated wells
received either DM -deficient CD4 25  cells (5   104), B6 CD4 25  cells (5   104), or B6 CD4 25  cells (5   104) and anti-CD3  (1  g/ml). Wells
were cultured for 96 h and pulsed with [3H]thymidine for the final 16 h and harvested. (C) CD4 25  cells (5   104) from DM -deficient or B6 mice were
cultured with either DM -deficient or B6, T cell–depleted splenocytes (2   105), and rIL-2 (10 U/ml) as indicated, for 96 h. Wells were pulsed with
[3H]thymidine for the final 16 h and harvested. Results are representative of three experiments.436 Selection of CD4 25  T Cells
antigens which is also mediated by regulatory CD4  cells
(10). Indeed, Coutinho and his colleagues first proposed
that regulatory cells developed after high avidity interac-
tions with thymic epithelium. However, in both of these
model systems the individual role of cortical and medullary
epithelium could not be distinguished. Our observation
that immunoregulatory CD4 25  T cells are present in
K14-A 
b (Fig. 1 A) suggests that, similar to other CD4  T
cells, positive selection on cortical epithelium is necessary
and sufficient for their differentiation from DP precursors.
Our experiments do not rule out the possibility that
medullary epithelium and bone marrow–derived APCs
play an inductive role that does not require MHC–TCR
interactions. Punt, Singer, and colleagues have suggested
that such a two-step strategy of clonal deletion operates to
purge autoreactive DP thymocytes which encountered
cognate self-antigen on cortical epithelium and the devel-
opment of regulatory T cells could have a similar require-
ment (41). The current systems do not permit us to distin-
guish these possibilities.
CD4 25  T Cells Do Not Require Peripheral MHC Ex-
pression for Development. It has been suggested in an ani-
mal model of thyroiditis that antigen-specific regulatory T
cells require the relevant autoantigen in the periphery for
complete function (42). However, this study monitored
the onset of autoimmune disease as a marker of the pres-
ence of functional regulatory cells and did not distinguish
development of suppressor cells from either persistence of
these cells in the peripheral T cell pool or activation to
suppress autoreactivity. Additionally, recent examination
by Tung and his colleagues of autoimmune oophoritis
showed that persistence of a relevant self-antigen in the pe-
riphery is required for the maintenance of T cell tolerance
(43). Our results indicate that cognate recognition of
MHC class II molecules in the periphery is not an absolute
requirement for development of the regulatory population
of CD4  cells in that we have clearly shown that there is a
significant number of functional CD4 25  T cells in the
periphery of K14-A 
b mice (Fig. 1 A and 2 B). While it re-
mains possible that K14-A 
b mice express MHC class II on
squamous epithelium (expression can be induced on kera-
tinocytes during inflammation, unpublished data), the ex-
pression levels in disease-free mice are below our ability to
detect by immunohistochemistry or FACS® (21) and insuf-
ficient to drive allogeneic CD4  T cell proliferation (Fig. 3
C). As K14-A 
b CD4 25  T cells can be activated by B6
APCs to suppress a K14-A 
b anti-B6 MLR, these cells rec-
ognize self-antigens on I-Ab-positive hematopoietic APCs
which are not present in either the thymus or the periph-
ery of K14-A 
b mice. We have not directly examined sup-
pression of organ-specific autoimmunity and it remains
possible that activation of suppressor cells in the periphery
requires the presence of the inciting autoantigen. Never-
theless, our data indicate that peripheral MHC class II is
not required for the development of functional CD4 25 
immunoregulatory T cells.
CD4 25  T Cells Can Be Subject to Deletion. In K14-A 
b
mice, the thymic cell types which can mediate clonal dele-
tion (hematopoietic APCs and medullary epithelium) are
MHC class II-negative. In this setting, we have previously
shown that  15% of the K14-A 
b CD4  T cell repertoire
responds to B6 hematopoietic APCs (21). Therefore, it is
striking that the MHC class II antigen reactivity of K14-
A 
b CD4 25  T subset mirrors this autoreactivity and is
significantly different from that of B6 CD4 25  T cells.
Activation of regulatory CD4 25  T cells by self-anti-
gens suppresses autoimmunity. It is, thus, quite surprising
that the peripheral CD4 25  T cell population of B6 mice
neither proliferates to nor suppresses an anti-B6 MLR
response. These data indicate that the repertoire of
B6 CD4 25  T cells differs significantly from K14-A 
b
CD4 25  T cells in that it has been purged of cells specific
for self-hematopoietic APCs. The restriction pattern of
CD4 25  T cells seems to mirror the repertoire of the ef-
fector CD4  T cell populations selected in the same thy-
mus. It could be argued that the CD4  T cell specificities
generated in K14-A 
b mice represent the positively selected
CD4  T cell repertoire before efficient clonal deletion.
Thus, our observation that K14-A 
b CD4 25  T cells, but
not B6 CD4 25  T cells, are activated by syngeneic APCs
suggests that expression of MHC class II on hematopoietic
APCs results in the deletion of a subset of CD4 25  thy-
mocytes that are reactive to self-antigens expressed on he-
matopoietic APCs.
We turned to H2-DM –deficient mice to extend these
observations about the repertoire of CD4 25  T cells (22–
24). Similar to K14-A 
b mice, these mice also have attenu-
ated negative selection. Similar to K14-A 
b CD4 25  T
cells, the repertoire of H2-DM –deficient CD4 25  T
cells also parallels that of the effector CD4  T cell popula-
tion. A simple explanation for these data would be that re-
striction of CD4 25  regulatory T cells occurs at the level
of the T cell, that regulatory cells suppress autoreactive T
cells which arise in the same thymus. However, wild-type
(B6) CD4 25  T cells can be activated by TCR signals
supplied by anti-CD3  to suppress both K14-A 
b and H2-
DM –deficient effector cells, arguing that there is a defi-
ciency in the B6 regulatory T cell repertoire rather than its
function. These data argue that the repertoire differences
noted for K14-A 
b CD4 25  T cells are not unique to the
K14-A 
b system and that our conclusions that CD4 25  T
cells are subject to clonal deletion on APCs may be gener-
alized. These results also suggest that regulatory CD4 25 
T cells don’t function in vivo in the periphery to prevent
autoreactivity to self dendritic cells, presumably because
tolerance to self-peptides present on hematopoietic APCs is
mediated by clonal deletion. Rather, we would propose
that CD4 25  T cells routinely function to suppress reac-
tivity to peripheral antigens which cannot induce deletion.
A Model for Development of CD4 25  T Cells. Recently,
two of us have reported that development of regulatory
CD4 25  cells in a TCR transgenic system occurs after
high affinity interactions with agonist self-peptide on thy-
mic epithelium (19). In this model, it was proposed that
generation of these cells was a high avidity event on med-
ullary epithelium (19, 20). Analysis of the K14-A 
b system437 Bensinger et al.
demonstrates that cognate interactions with MHC class II-
positive cortical epithelium results in the development of
functional CD4 25  regulatory T cells. We also hypothe-
size that positively selected CD4 25  thymocytes which
recognize ubiquitous self-antigens with high affinity are
subject to negative selection on hematopoietic APCs.
Therefore, a subset of CD4 25  T cells which are nega-
tively selected in wild-type mice remain present in K14-
A 
b and H2-DM –deficient thymi and can function to
suppress an anti-B6 MLR. These selection events would
restrict the repertoire of developing CD4 25  T cells to
tissue (epithelial)-specific antigens. This scenario is consis-
tent with the previous observations that depletion and or
manipulation of CD4 25  T cells in wild-type animals re-
sults in organ-specific autoimmune disease rather than sys-
temic autoimmunity.
We suggest that high affinity cognate interactions be-
tween developing CD4  T cells and self-peptides on thy-
mic cortical epithelium leads to self-tolerance through the
induction of regulatory T cells. Recently, Hogquist and
colleagues used the K14 promoter to target an MHC class
I–restricted high affinity peptide to thymic cortical epithe-
lium (44). In this system, they noted the reexpression of
RAG proteins and receptor editing, rather than clonal de-
letion of self-reactive cells. Taken together with the data
presented in this report, these results suggest that thy-
mic cortical epithelium induces tolerance to self-antigens
through nondeletional mechanisms.
In conclusion, our results indicate that anergic/suppres-
sive CD4 25  T cells are selected through cognate interac-
tions on thymic cortical epithelium and are subject to
clonal deletion on hematopoietic APCs.
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